P

    Precigen Inc (PGEN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.93
    -0.02 (-0.29%)

    Market Cap: $2.49B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    43%(17/40)
    Avg Surprise
    -55.08%
    Streak
    3 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.08
    Range$0.05 - $0.14
    3 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$-0.02-125.5%
    60d ago$-0.00-102.9%
    30d ago$-0.00-104.2%
    7d ago$-0.00-104.2%
    Current$0.08
    Revenue Consensus
    $69M
    Range$60M - $87M
    3 analysts
    Dec 31, 2026
    EPS Consensus$0.20
    Range$0.11 - $0.36
    3 analysts
    Revenue Consensus
    $115M
    Range$86M - $167M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.20---
    Sep 26EST
    		-$0.08---
    Jun 26
    		$0.05$-0.02+350.00%Beat+162.5%
    Mar 26
    		$-0.02$-0.04+50.00%Beat+88.9%
    Dec 25
    		$-0.07$-0.08+20.29%Beat-66.0%
    Sep 25
    		$-1.06$-0.09-1077.78%Miss-1077.8%
    Jun 25
    		$-0.08$-0.08+0.00%Beat+20.0%
    Mar 25
    		$-0.18$-0.08-125.00%Miss-80.0%
    Dec 24
    		$-0.04$-0.06+33.33%Beat+69.2%
    Sep 24
    		$-0.09$-0.09+0.00%Beat-12.5%
    Jun 24
    		$-0.10$-0.09-11.11%Miss-25.0%
    Mar 24
    		$-0.10$-0.08-25.00%Miss+0.0%
    Dec 23
    		$-0.13$-0.08-62.50%Miss-18.2%
    Sep 23
    		$-0.08$-0.08+0.00%Beat-100.0%
    Jun 23
    		$-0.08$-0.10+20.00%Beat+0.0%
    Mar 23
    		$-0.10$-0.09-11.11%Miss+0.0%
    Dec 22
    		$-0.11$-0.12+8.33%Beat+15.4%
    Sep 22
    		$-0.04N/A+55.56%Beat+73.3%
    Jun 22
    		$-0.08$-0.14+42.86%Beat+20.0%
    Mar 22
    		$-0.10$-0.13+23.08%Beat+9.1%
    Dec 21
    		$-0.13$-0.12-8.33%Miss+43.5%
    Sep 21
    		$-0.15$-0.13-15.38%Miss+16.7%
    Jun 21
    		$-0.10$-0.12+16.67%Beat+61.5%
    Mar 21
    		$-0.11$-0.15+26.67%Beat+68.6%
    Dec 20
    		$-0.23$-0.17-35.29%Miss+17.9%
    Sep 20
    		$-0.18$-0.14-28.57%Miss+48.6%
    Jun 20
    		$-0.26$-0.13-100.00%Miss-4.0%
    Mar 20
    		$-0.35$-0.24-45.83%Miss+12.5%
    Dec 19
    		$-0.28$-0.29+3.45%Beat+89.2%
    Sep 19
    		$-0.35$-0.25-40.00%Miss+20.5%
    Jun 19
    		$-0.25$-0.29+13.79%Beat+51.0%
    Mar 19
    		$-0.40$-0.25-60.00%Miss-25.0%
    Dec 18
    		$-2.59$-0.34-661.76%Miss-2777.8%
    Sep 18
    		$-0.44$-0.23-91.30%Miss-25.7%
    Jun 18
    		$-0.51$-0.23-121.74%Miss-121.7%
    Mar 18
    		$-0.32$-0.24-33.33%Miss-28.0%
    Dec 17
    		$-0.09N/A+71.88%Beat+75.7%
    Sep 17
    		$-0.35$-0.15-133.33%Miss-40.0%
    Jun 17
    		$-0.23$-0.10-130.00%Miss-
    Mar 17
    		$-0.25$-0.22-13.64%Miss-
    Dec 16
    		$-0.37$-0.23-60.87%Miss-
    Sep 16
    		$-0.25$-0.17-47.06%Miss-

    Dividends

    Dividend Metrics

    Yield0.00%
    Annual/Share$0.00
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E Ratio-6.32EV/EBITDA-3.31x
    Price/FCF-21.47xFCF Yield-4.66%
    Profitability
    Profit Margin-184.00%Operating Margin41.20%
    ROE-837.00%ROIC-86.57%
    Financial Health
    Debt/Equity2.15xInterest Coverage-1.26x
    Current Ratio4.58xQuick Ratio3.89x
    Trading Statistics
    Beta1.01Avg Volume6.31M
    52-Week High$7.7252-Week Low$2.99

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.15
    SMA 20$6.95
    SMA 50$6.08
    SMA 200$4.59
    EMA 10$7.04
    EMA 20$6.82
    EMA 50$6.14
    EMA 200$4.72

    MACD

    Line: 0.34Signal: 0.39Hist: -0.05

    ADX

    ADX: 31.4+DI: 28.6-DI: 22.9

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down4.0
    PSAR$7.71

    Bollinger Bands

    Upper Band$7.63
    Lower Band$6.26
    %B Position1959%(Upper)
    Band Width0.49

    RSI (14-Day)

    Neutral
    55.4

    Momentum Oscillators

    Stoch %K57.7
    Stoch %D67.5
    Williams %R-48.0
    ROC (10d)5.8%
    Momentum0.38
    CCI (20d)-26.1
    MFI (14d)52.5

    Volatility Measures

    ATR (14d)$0.39(5.7%)
    StdDev (20d)0.34
    Hist Vol61.2%(High)

    Volume Flow

    VWAP$6.84
    OBV264.9M
    AD Line-18.3M
    CMF (20d)-0.031

    Volume Metrics

    Avg Vol (20d)6.2M
    Vol Ratio0.7x
    VWMA (20d)$6.93

    Pivot Points

    R3$7.39
    R2$7.29
    R1$7.12
    Pivot Point$7.02
    S1$6.85
    S2$6.75
    S3$6.58

    Advanced Oscillators

    TSI22.93
    Ultimate Osc45.8
    KST229.95

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$54.98M$23.25M$3.71M$2.92M$856,000$1.34M$473,000$953,000$1.43M$1.06M$1.23M$1.38M
    Cost of Revenue$2.81M$2.56M$1.60M$1.03M$1.09M$1.10M$1.17M$1.01M$1.01M$1.07M$1.36M$1.54M
    Gross Profit$52.17M$20.69M$2.11M$1.89M$-236,000$241,000$-696,000$-56,000$420,000$-10,000$-130,000$-158,000
    Operating Expenses$29.53M$26.69M$24.64M$36.37M$31.53M$22.84M$28.54M$21.21M$60.54M$24.40M$34.09M$20.78M
    R&D$7.28M$5.64M$6.99M$12.38M$11.49M$10.48M$11.76M$11.37M$15.69M$14.25M$12.99M$11.58M
    SG&A$22.25M$21.05M$17.64M$23.99M$16.13M$12.36M$11.00M$9.84M$10.31M$10.15M$10.26M$9.20M
    Operating Income$22.64M$-5,994,000$-21,666,000$-34,481,000$-31,764,000$-22,596,000$-28,516,000$-21,262,000$-60,841,000$-24,410,000$-34,223,000$-20,937,000
    Interest Income$366,000$683,000$1.07M$534,000$696,000$918,000$208,000$283,000$319,000$608,000$920,000$856,000
    Interest Expense$2.95M$2.91M$1.84M$111.86M$0$1,000$15.06M$2.70M$2,000$0$0$0
    Income Before Tax$20.07M$-7,929,000$-23,503,000$-146,344,000$-26,639,000$-54,153,000$-43,581,000$-23,966,000$-60,481,000$0$-33,388,000$-19,801,000
    Income Tax Expense$0$0$0$0$3,000$0$-70,000$24,000$-1,689,000$-58,000$-277,000$-6,000
    Net Income$20.07M$-7,929,000$-23,503,000$-146,344,000$-26,642,000$-54,153,000$-19,727,000$-23,978,000$-58,792,000$-23,738,000$-33,056,000$-19,795,000
    EBITDA$23.91M$-4,629,000$-20,898,000$-145,419,000$-27,173,000$-55,147,000$-19,512,000$-23,735,000$-59,375,000$-23,175,000$-33,202,000$-19,579,000
    EBIT$22.66M$-5,704,000$-21,606,000$-145,976,000$-27,335,000$-55,070,000$-20,022,000$-24,247,000$-60,798,000$-24,373,000$-34,301,000$-20,656,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PGEN

    News

    Precigen CCO Phil Tennant sells $593,745 in stock

    Precigen's Chief Commercial Officer, Phil Tennant, sold 79,166 shares of company stock for $593,745. This sale occurred while the stock was trading near its 52-week high after an 83% gain over the past year. The transaction was made according to a pre-arranged 10b5-1 trading plan and followed his acquisition of shares through RSU settlements and option exercises.

    Investing.com•8/25/26•
    Somewhat-Bullish

    Precigen COO Rutul Shah sells $375,000 in shares

    Precigen's COO, Rutul R. Shah, sold 50,000 shares of the company's stock in two transactions in late August 2026, totaling approximately $375,000. These sales occurred after Shah acquired shares through stock option exercises and RSU settlements, with the stock trading near its 52-week high. The company recently reported strong Q2 results, exceeding revenue and earnings expectations, largely due to demand for its PAPZIMEOS therapy.

    Investing.com•8/25/26•
    Neutral

    Precigen (NASDAQ: PGEN) CFO settles RSUs, withholds 3,577 shares for taxes

    Precigen's (NASDAQ: PGEN) CFO, Harry Thomasian Jr., settled 7,291 Restricted Stock Units (RSUs) on August 23, 2026, which converted into common stock. To cover income tax withholding obligations, 3,577 shares were withheld at a value of $7.20 per share, categorized as a code F disposition. Following these transactions, Thomasian Jr. directly holds 80,209 RSUs, with no open market purchases or sales reported.

    Stock Titan•8/25/26•
    Neutral

    Precigen (PGEN) COO unloads 50K shares at $7.50 under plan

    Precigen's (PGEN) Chief Operating Officer, Rutul R. Shah, exercised stock options and RSUs and subsequently sold 50,000 common shares at $7.50 per share through a Rule 10b5-1 trading plan. The transactions occurred on August 21 and 25, 2026, following the exercise of options at $2.33 per share. Additionally, 7,500 RSUs converted to common stock on August 23, 2026, with some shares withheld for tax obligations.

    Stock Titan•8/25/26•
    Neutral

    Precigen (PGEN) insider lines up another stock sale after four recent trades

    Precigen (PGEN) officer Rutul Shah plans to sell 15,342 common shares valued at approximately $115,065.00 through Fidelity Brokerage Services LLC on or after August 25, 2026, following a stock option exercise. This proposed sale comes after four previous sales of Precigen common shares by the same individual within the prior three months, totaling over $950,000. The transaction was disclosed via a Form 144 SEC filing.

    Stock Titan•8/25/26•
    Neutral

    Frequently Asked Questions About PGEN

    Does PGEN pay dividends?
    Precigen Inc (PGEN) has a dividend payment track record. See the PGEN dividend history page for its current payment status, yield, and streaks.
    What is PGEN's market cap?
    Precigen Inc (PGEN) has a market capitalization of $2.49B with a current stock price of $6.93.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In